Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06156254 · ClinicalTrials.gov registry record · NA

Community Care Intervention to Decrease COVID-19 Vaccination Inequities

A NA study of COVID-19 Vaccination, sponsored by RAND.

Recruiting
Registry status
NA
Development phase
800
Enrollment target
4
Study locations

NCT06156254 is a NA study of COVID-19 Vaccination that is actively recruiting participants, run by RAND. The registered enrollment target is 800 participants. The trial reports 4 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06156254, a NA study of COVID-19 Vaccination, is actively recruiting participants, sponsored by RAND.

RECRUITING
Registry status
NA
Development phase
800 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this study is to find out if a community health workers (CHW) intervention conducted in Federally Qualified Health Centers (FQHCs) can increase the number of adults with chronic illnesses who are up-to-date with their COVID-19 and influenza vaccines.

Conditions Studied

Interventions

  • BEHAVIORAL Community Health Worker Intervention to Enhance Vaccination Behavior (CHW-VB)

Study Locations (4)

New York

  • Brownsville Multi-Service Health Center - Brooklyn
  • Bedford-Stuyvesant Family Health Center - Brooklyn
  • Community Healthcare Network - New York
  • Morris Heights Health Center - The Bronx

Trial Details

FieldValue
Enrollment Target 800 participants
Start Date 2023-09-21
Est. Completion 2026-06-01
Phase NA

Sponsor

RAND

78 total trials

What the Registry Record Tells You About NCT06156254

The ClinicalTrials.gov registry entry for NCT06156254 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RAND, which has 78 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with COVID-19 Vaccination appearing as the primary indexed condition, and to 1 intervention - of which Community Health Worker Intervention to Enhance Vaccination Behavior (CHW-VB) is the first listed.

NCT06156254 reports 4 study locations spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06156254 about?

NCT06156254 is a clinical study titled "Community Care Intervention to Decrease COVID-19 Vaccination Inequities". The purpose of this study is to find out if a community health workers (CHW) intervention conducted in Federally Qualified Health Centers (FQHCs) can increase the number of adults with chronic illnesses who are up-to-date with their COVID-19 and influenza vaccines.

What is the current status of trial NCT06156254?

This trial is currently recruiting. It is a NA study. The enrollment target is 800 participants. The study started on 2023-09-21. Estimated completion is 2026-06-01.

What conditions does trial NCT06156254 study?

This clinical trial studies the following conditions: COVID-19 Vaccination.

What interventions are being tested in trial NCT06156254?

The interventions under investigation include: Community Health Worker Intervention to Enhance Vaccination Behavior (CHW-VB) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06156254?

This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06156254 being conducted?

This trial has 4 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COVID-19 Vaccination

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.